N4 Pharma Plc (LON:N4P – Get Free Report) shares traded down 14.7% during trading on Thursday . The company traded as low as GBX 0.51 ($0.01) and last traded at GBX 0.51 ($0.01). 241,998 shares traded hands during trading, a decline of 77% from the average session volume of 1,055,165 shares. The stock had previously closed at GBX 0.60 ($0.01).
N4 Pharma Trading Down 14.7 %
The company has a quick ratio of 7.28, a current ratio of 14.86 and a debt-to-equity ratio of 1.62. The firm has a market cap of £2.02 million, a price-to-earnings ratio of -60.00 and a beta of -0.37. The business has a 50 day moving average of GBX 0.54 and a 200 day moving average of GBX 0.62.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Featured Stories
- Five stocks we like better than N4 Pharma
- What is a Special Dividend?
- Should You Invest in Treasury Bills?
- What are earnings reports?
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
